Form 1-K — 20/20 Biolabs, Inc.
0001213900-25-037678 · filed Apr 30, 2025
Offering
- Total offering
- —
- Total sold
- —
- Security type
- —
- Price per security
- —
- Over-allotment
- —
- Jurisdictions
- —
Issuer
- CIK
- 1139685
- Entity
- Corporation
- Jurisdiction
- Delaware
- Address
- 15810 GAITHER ROAD, SUITE 235
GAITHERSBURG, Maryland 20877
Most recent fiscal year financials
Financial statement requirements vary by tier and report. Verify the audit or review status in the original SEC filing.
- Total assets
- —
- Total liabilities
- —
- Cash
- —
- Total revenues
- —
- Net income
- —
Same issuer's Form D filings
-
D · Feb 26, 2025$3M
Same issuer's Reg CF (Form C) raises
View the original filing on SEC EDGAR ↗